Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Chemotherapy|September 1, 1995
Ribonucleotide reductase: an important enzyme in the replication of herpes simplex virus type 1 and a target for antiviral chemotherapyM N Prichard, C ShipmanAntiviral Research|October 1, 1990
A three-dimensional model to analyze drug-drug interactionsM N Prichard, C ShipmanInfectious Disorders Drug Targets|August 11, 2011
The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysisS H James, M N PrichardAntimicrobial Agents and Chemotherapy|March 1, 1993
Strategic design and three-dimensional analysis of antiviral drug combinationsM N Prichard, L E Prichard, C ShipmanAntiviral Research|March 1, 1993
Inhibitors of thymidylate synthase and dihydrofolate reductase potentiate the antiviral effect of acyclovirM N Prichard, L E Prichard, C ShipmanJournal of Virology|May 1, 1996
Human cytomegalovirus uracil DNA glycosylase is required for the normal temporal regulation of both DNA synthesis and viral replicationM N Prichard, G M Duke, E S MocarskiJournal of Virology|July 20, 2001
Requirement for uracil-DNA glycosylase during the transition to late-phase cytomegalovirus DNA replicationC T Courcelle, J Courcelle, M N Prichard, et al.Clinical Pharmacology and Therapeutics|February 12, 2015
Helicase-primase as a target of new therapies for herpes simplex virus infectionsS H James, K B Larson, E P Acosta, et al.Proceedings of the National Academy of Sciences of the United States of America|February 15, 2001
Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidationD G Wolf, C T Courcelle, M N Prichard, et al.Virology|January 14, 1998
Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genomeE S Mocarski, M N Prichard, C S Tan, et al.Pageof 2